Improving GP diabetes management. A PDSA audit cycle in Western Australia

Australian Family Physician

Volumn 38, Issue 11, 2009, Pages 939-344

  Porter, Cynthia ^a   Greenfield, Charlie ^b   Larson, Ann ^a   Gilles, Marisa ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Rural Clinical School   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE MANAGEMENT; FEMALE; GENERAL PRACTICE; HEALTH CARE QUALITY; HUMAN; MALE; MEDICAL AUDIT; METHODOLOGY; MIDDLE AGED; MORBIDITY; MULTICENTER STUDY; RETROSPECTIVE STUDY; STANDARD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; COMMISSION ON PROFESSIONAL AND HOSPITAL ACTIVITIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DISEASE MANAGEMENT; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MIDDLE AGED; MORBIDITY; QUALITY ASSURANCE, HEALTH CARE; RETROSPECTIVE STUDIES; WESTERN AUSTRALIA; YOUNG ADULT;

EID: 73049104559     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Stratton IM, Cull CA, Alder AI, et al. Additive effects of glycaemic and blood pressure exposure on risk of complications in type 2 diabetes: A prospective observational study (UKPDS 75). Diabetologia 2006;49:1761-9.
2. Homan RR, Paul SK, Bethel MA, et al. Long term follow up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008;359:1565-76.
3. Homan RR, Paul SK, Bethel MA, et al. 10 year follow up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-89.
4. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 1998;317:703-13
5. Patel A, MacMahon S, Chalmers J, et al. Effects of a fixed combination of perin- dopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised control trial. Lancet 2007;370:829-40.
6. Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy of cholesterol lowering therapy in 18686 people with diabetes in 14 randomised trials of statins: A meta-analysis. Lancet 2008;371:117-25.
7. Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycaemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy.Diabetologia 2006;49:1711-21.
8. Wan Q, Taggart J, Harris MF, et al. Investigation of cardiovascular risk factors in type 2 diabetes in a rural Australian division of general practice. Med J Aust 2008;189:86-9.
9. Bryant W, Greenfield JR, Chisholm DJ, Campbell L. A retrospective audit of outpatient management of type 1 and type 2 diabetes mellitus. Med J Aust 2006;185:305-9.
10. Landon BE, Hicks LS, O'Malley AJ, et al. Improving the management of chronic disease at community health centers. N Engl J Med 2007;356:921-34.
11. The Royal Australian College of General Practitioners. The QA&CPD Program Handbook, 2005-2007 triennium. South Melbourne: The RACGP, 2005.
12. Porter C, Wheatland B, Gilles M, Greenfield C, Larson A. Initiating a PDSA cycle - improving management of diabetes in rural WA. Aust Fam Physician 2006;35:650-2.
13. Bonney M, Burns J, Harris M. Recommended GP subset of the NDOQRIN dataset and alternative fields from which NDOQRIN fields can subsequently be derived. Sydney: Centre for General Practice Integration Studies, School of Community Medicine, UNSW, 1999.
14. Harris P, Joyner B, Phillips P, Webster C. Diabetes management in general practice 2004/5. Canberra: Diabetes Australia/The RACGP, 2005.
15. Statistical Package for Social Sciences (SPSS) for Windows [computer software]. Release 17. Chicago: SPSS Inc, 2007.
16. Campbell SM, Roland MO, Middleton E, Reeves D. Improvements in quality of clinical care in English general practice 1998-2003: Longitudinal observational study. BMJ 2005;331:112-36.
17. Hippisley-Cox J, Pringle M. Prevalence, care, and outcomes for patients with diet controlled diabetes in general practice: cross sectional survey. Lancet 2004;364:423-8.
18. Medicare Australia. Divisions of General Practice Statistics Reports (report on PBS information). Available at www.medicareaustralia.gov.au/statistics/div_gen_prac.shtml [Accessed 28 September 2008].
19. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension and cardiovascular disease: An update. Hypertension 2001;37:1053-9.
20. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. JAMA 2003;289:2560-72.
21. Kerr EA, Zikmund-Fisher BJ, Klamerus ML, et al. The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure. Ann Intern Med 2008;148:717-27.
22. Heisler M, Hogan MM, Hofer TP, et al. When more is not better. Treatment intensification among hypertensive patients with poor medication adherence. Circulation 2008;117:2884-92.
23. Atreja A, Bellam N, Levy SR. Strategies to enhance patient adherence: Making it simple. MedGenMed 2007;7:4.
24. Hayhow BD, Lowe MP. Addicted to the good life: Harm reduction in chronic disease management. Med J Aust 2006;184:235-7.
25. Harris M. Challenges in diabetes management. Aust Fam Physician 2008;37:716-20.
26. Gaede P, Lund-Anderson H, Parving HH, Pederson O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008;358:580-91.